Bayesian applications in pharmaceutical statistics

[1]  S. Morita,et al.  Bayesian dose‐finding phase I trial design incorporating historical data from a preceding trial , 2018, Pharmaceutical statistics.

[2]  Nicky Best,et al.  Better decision making in drug development through adoption of formal prior elicitation , 2017, Pharmaceutical statistics.

[3]  A. Grieve,et al.  Response‐adaptive clinical trials: case studies in the medical literature , 2017, Pharmaceutical statistics.

[4]  R. Edlin,et al.  Bayesian statistical models to estimate EQ‐5D utility scores from EORTC QLQ data in myeloma , 2018, Pharmaceutical statistics.

[5]  Phil Woodward,et al.  Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study , 2015, Pharmaceutical statistics.

[6]  Anthony O'Hagan,et al.  Assurance in clinical trial design , 2005 .

[7]  Andrew P Grieve,et al.  Idle thoughts of a ‘well‐calibrated’ Bayesian in clinical drug development , 2016, Pharmaceutical statistics.

[8]  Satoshi Morita,et al.  BOIN‐ET: Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes , 2018, Pharmaceutical statistics.

[9]  J. Seaman,et al.  The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group , 2014, Pharmaceutical statistics.

[10]  Samiran Ghosh,et al.  Bayesian approach for assessing noninferiority in a three‐arm trial with binary endpoint , 2018, Pharmaceutical statistics.

[11]  Bradley P Carlin,et al.  Guidance on the implementation and reporting of a drug safety Bayesian network meta‐analysis , 2014, Pharmaceutical statistics.

[12]  A. F. Smith,et al.  Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry , 1986 .

[13]  Andrew P Grieve,et al.  25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel , 2007, Pharmaceutical statistics.

[14]  Nicky Best,et al.  Practical experiences of adopting assurance as a quantitative framework to support decision making in drug development , 2018, Pharmaceutical statistics.

[15]  Armin Koch,et al.  How to use prior knowledge and still give new data a chance? , 2018, Pharmaceutical statistics.